Search results for: 'Industry Report on Security System Integration Project Analysis in Central Asia'
- Related search terms
- analysis of the north american radiology image and information management systemnorth american radiology pacs and (ris(ris pacs) market
- analysis of the drug delivery devices market forecast to 2023
- report self-driving cars technology will enable a new passenger and delivery economy predicted to have a global market of $173B
- analysis-of-top-30-features-of-mass-market-and-luxury-oems-in-northt-america
- analysis-of-the-ethiopian-pharmaceutical-market.html®ions=234
-
18 Sep 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in AI-Enabled Discovery and Diagnostics, Precision Therapeutics, and Next-Generation Vaccine Platforms
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming AI-enabled discovery, precision diagnostics, cell engineering, targeted therapeutics, vaccines, and skin health across oncology, metabolic disease, rare disorders, neuropsychiatry, and ne...
$950.00 -
22 Apr 2026  |  Global  |  Market Research
Top 5 Key Takeaways from the Scope Summit, 2026
AI Adoption in Clinical Research has Moved from Exploration to Execution
The SCOPE Summit 2026, held in Orlando, Florida, from February 2 to 5, 2026, highlighted the dominance of small- to mid-segment companies and specialized CROs focusing on specific therapy areas or aspects of clinical trials, such as bioanalysis. With more than 4,000 attendees, 630 speakers, and 300 exhibitors, SCOPE 2026 reinforced its position as ...
$2,450.00 -
15 Oct 2026  |  Global  |  Frost Radar
Frost Radar™: US and European Mammalian Contract Development and Manufacturing Organizations, 2026
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
The US and European mammalian contract development and manufacturing organization (CDMO) market is entering a new phase of strategic evolution, driven by accelerating biologics outsourcing, increasing molecule complexity, and growing demand for resilient, end-to-end manufacturing partnerships. As monoclonal antibodies, bispecific antibodies, Fc-fus...
$4,950.00 -
27 Sep 2017  |  Africa  |  Market Research
East African Pharmaceutical Market, Forecast to 2021
Generic Pharmaceutical Products Continue to Dominate with Increased Foreign Direct Investment by Asian Manufacturers
Pharmaceutical markets in Sub-Saharan Africa are experiencing rapid growth as governments and healthcare providers battle with their respective burdens of disease. The continent has one of the highest burdens of disease, such as HIV, malaria, and tuberculosis, yet has limited healthcare resources and spending. As such there are great opportunities ...
$4,950.00
Special Price $3,712.50 save 25 %
-
19 Apr 2017  |  Asia Pacific  |  Market Research
Global CRO Market, Forecast to 2021
The Global CRO Market to Reach $64.58 Billion by 2021
The Global CRO Market, Forecast to 2021, presents an overview and analysis of the global clinical trials and research outsourcing (CRO) market. It provides revenue forecasts for CROs globally by phase, therapeutic type and region. With the consolidation of the market as well as a higher cost and risk involved, the big companies are slowly shifting ...
$4,950.00
Special Price $3,712.50 save 25 %
-
07 Sep 2026  |  Global  |  Technology Research
Synthetic Antibodies and AI-Optimized Immunotherapies
Technology Advancements, Clinical Progress, and Growth Opportunities in AI-Enabled Antibody Therapeutics
Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion models, and structure-based models are expanding the u...
$4,950.00 -
15 May 2025  |  Global  |  Market Research
Immunomodulator Therapeutics Market, Global, 2024–2030
Mechanism-targeted Approaches are Driving Transformational Growth by Enabling Innovation in Autoimmune, Oncology, and Inflammatory Therapies
This research service offers a comprehensive analysis of the global immunomodulator therapeutics market, specifically targeting inflammatory disorders in the immunology, gastrointestinal (GI), and dermatology segments. The report defines this market through products designed to modify and regulate pathological immune responses, either by inhibiting...
$4,950.00
Special Price $4,455.00 save 10 %
-
11 Nov 2025  |  Global  |  Technology Research
Frost Radar™: Digital Biomanufacturing of Viral Vectors, 2025
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
Viral vectors are a critical part of gene therapies and genetic medicines, which are the cornerstone of precision medicines to cure rare diseases, cancers, and genetic disorders. Traditional bioprocessing, however, is tedious, less flexible, batch-based, and heavily manual; as a result, manufacturing processes involve high costs, scalability issues...
$4,950.00 -
05 May 2026  |  Global  |  Market Research
Growth Opportunities in Biologics Contract Development & Manufacturing Organizations, Global, 2026–2031
Targeted ADC Upstream and Aseptic Fill-Finish Expansion Expected to Resolve Regional Capacity Gaps and Drive Bio-CDMO Growth
The bio‑CDMO industry is entering an era of accelerated growth driven by the global shift toward complex biologics, including monoclonal antibodies, antibody-drug conjugates (ADCs), cell and gene therapies, recombinant proteins, and advanced vaccines. Large molecules are projected to record a 10.3% CAGR between 2025 and 2031, signaling sustained de...
$2,450.00 -
05 Aug 2025  |  Global  |  Market Research
Growth Opportunities in the Immuno-oncology Therapeutics Market, 2024–2030
Advances in Next-Generation Immunotherapies, AI, and Biomarker-Driven Personalization are Driving Transformational Growth
Worldwide cancer incidence is expected to exceed 35 million new cases by 2050, a 77% rise from the 20 million cases in 2022. Alcohol intake, tobacco usage, obesity, and air pollution are the main causes of this increase. Cancer studies today emphasize cell and gene therapy, antibody-drug conjugates (ADCs), checkpoint inhibitors, and multi-specific...
$4,950.00